
CAS 1826865-46-6
:ZLD-1039
Description:
ZLD-1039, identified by its CAS number 1826865-46-6, is a chemical compound that falls within the category of small molecules, often utilized in pharmaceutical research and development. While specific characteristics such as its molecular formula, structure, and physical properties may vary, compounds like ZLD-1039 are typically evaluated for their biological activity, solubility, stability, and potential therapeutic applications. In the context of drug discovery, such substances are often screened for efficacy against specific biological targets, and their safety profiles are assessed through various preclinical studies. The compound may exhibit unique interactions with biological systems, making it a candidate for further investigation in medicinal chemistry. As with any chemical substance, handling ZLD-1039 requires adherence to safety protocols, including proper storage and disposal methods, to mitigate any potential hazards associated with its use. For detailed information, including specific applications and research findings, consulting scientific literature and databases is recommended.
Formula:C36H48N6O3
Synonyms:- 3-[ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO]-N-[(2;3;5;6;7;8-HEXAHYDRO-1-METHYL-3-OXO-4-ISOQUINOLINYL)METHYL]-2-METHYL-5-[6-(4-METHYL-1-PIPERAZINYL)-3-PYRIDINYL]-BENZAMIDE
- ZLD-1039
- Benzamide, 3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-
- 3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2
- 8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-benzamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
3-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-benzamide
CAS:Formula:C36H48N6O3Purity:98%Molecular weight:612.8047ZLD 1039
CAS:ZLD 1039 is an activating compound that has been shown to modulate the immune system and activate the production of antibodies. This drug is a heterologous adjuvant that can be used in vaccine strategies to promote immunity. ZLD 1039 has been found to increase the production of pluripotent stem cells, which are cells that have the potential to differentiate into any type of cell in the body. The acetylation status of ZLD 1039 was found to correlate with its ability to promote pluripotency. ZLD 1039 has also been shown to alter DNA methylation patterns and markers on cancer cells.Formula:C36H48N6O3Purity:Min. 95%Molecular weight:612.8 g/molZLD1039
CAS:ZLD1039, an oral EZH2 inhibitor, shows strong PRC2 inhibition at low nanomolar IC50s, and halts breast cancer growth and spread.Formula:C36H48N6O3Purity:99.5%Color and Shape:SolidMolecular weight:612.8



